Company / Cash & Equivalents
Brookdale Senior Living Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$279.1M
FY2025
5-year range
$278.0M / $398.9M
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
#69 of 148
Health Care
What the data says
At $279M, Brookdale Senior Living Inc.'s cash & equivalents ranks #69 of 148 in the Health Care sector. Cash & Equivalents has fluctuated over the past 10 years, ranging from $216M in FY2016 to $399M in FY2022.
Based on SEC 10-K filings.
$279M in FY2025 with a 5-year CAGR of -6.0%.
Remained stable around $279M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -11.2%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
#69 of 148 in Health CareTop 47% of 148This company $279.1M Sector average $1.2B
▼
-76.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.0%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 9.6% year-over-year.
- Ranks #69 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.07 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $279.1M | -9.6% |
| FY2024 | $308.9M | +11.1% |
| FY2023 | $278.0M | -30.3% |
| FY2022 | $398.9M | +14.9% |
| FY2021 | $347.0M | -8.8% |
| FY2020 | $380.4M | +58.4% |
| FY2019 | $240.2M | -39.7% |
| FY2018 | $398.3M | +78.9% |
| FY2017 | $222.6M | +2.9% |
| FY2016 | $216.4M | +145.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026